Anticonvulsant effects of PGE2 on electrical, chemical and photomyoclonic animal models of epilepsy.
D000818:Animals; D000927:Anticonvulsants; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D015232:Dinoprostone; D004195:Disease Models, Animal; D004558:Electric Stimulation; D007538:Isoniazid / Q000494:pharmacology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D010215:Papio; D011458:Prostaglandins E / Q000627:therapeutic use*; D012640:Seizures / Q000188:drug therapy / Q000503:physiopathology*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000927:Anticonvulsants; D011458:Prostaglandins E; D005680:gamma-Aminobutyric Acid; D015232:Dinoprostone; D007538:Isoniazid